Hironobu Minami

Kobe University Hospital — Japan

Medicine · Health Sciences

54h-index15.0kcitations695works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Treatment and Pharmacology(61), Lung Cancer Treatments and Mutations(55), Chronic Lymphocytic Leukemia Research(49), Acute Myeloid Leukemia Research(46), Chronic Myeloid Leukemia Treatments(46)

Publications688 total

A phase II trial of nivolumab for patients with platinum-refractory recurrent or metastatic salivary gland cancer
Japanese Journal of Clinical Oncology·2025Open Access
Development and clinical evaluation of a cost-effective method with capillary electrophoresis sequencer-based fragment analysis assay panel for genetic classification and risk stratification in de novo AML
Blood·2025
Inhibition of prolyl-tRNA synthetase sensitizes acute myeloid leukemia to venetoclax through bmf-mediated apoptosis
Blood·2025
689 The mTORC1/2 dual inhibitor AZD2014 enhances inotuzumab ozogamicin-induced apoptosis in B-cell non-hodgkin lymphoma cells via lysosomal function activation
Regular and Young Investigator Award Abstracts·2025Open Access
Complex t(8;14;18)(q24;q32;q21) Together With Novel t(3;6)(q27;p23) in Triple‐Hit High‐Grade B‐Cell Lymphoma Showing Burkitt‐Like Cytology
International Journal of Laboratory Hematology·2025
Negative Impact of Coronavirus Disease 2019 Pandemic on Gastric Cancer Care in Japan: A Tokushukai Real‐World Data Project 08 ( <scp>TREAD</scp> 08)
JGH Open·2025Open Access
Barriers to career development and gender-related challenges in oncology: the results of the JSMO and JSCO surveys in Japan
ESMO Real World Data and Digital Oncology·2025Open Access
POSTER: ALL-724 First-in-Human Study of Asciminib Monotherapy in Adults With Relapsed/Refractory (R/R) Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Clinical Lymphoma Myeloma & Leukemia·2025
ALL-724: First-in-Human Study of Asciminib Monotherapy in Adults With Relapsed/Refractory (R/R) Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Clinical Lymphoma Myeloma & Leukemia·2025
Real-world evidence on the survival benefit of immune checkpoint inhibitors in combination with cytotoxic chemotherapy for patients with extensive-disease small-cell lung cancer: the Tokushukai Real World Data Project (TREAD) 06
BMC Cancer·2025Open Access
[Challenges and Prospects for Medical Oncology under the Emerging Infectious Disease Disaster].
PubMed·2025
Humoral immunity after hematopoietic stem cell transplantation: evaluation by B-cell receptor repertoire analysis
International Journal of Hematology·2025Open Access
Importance of E/e’ and BNP for early detection of late cardiotoxicity in long-term follow-up of childhood hematologic cancer survivors: a retrospective cross-sectional study
Cardio-Oncology·2025Open Access
Abstract P1-04-20: Difference in transcriptional expression and immune infiltration analysis between recurrent and de novo stage IV HER2-negative breast cancer in the NEWBEAT trial; WJOG9917BTR
Clinical Cancer Research·2025
A Rare Case of Pseudohypercalcemia Associated with Multiple Myeloma.
PubMed·2025Open Access
Ring Chromosomes 7 in Two Cases of Myelodysplastic Syndrome: Isolated Abnormality and Complex Karyotype Including idic(21)(p11.2) Duplication
International Journal of Laboratory Hematology·2025
Abstract LB078: Adipocytes promote cancer stem cell properties and metastatic progression in breast cancers
Cancer Research·2025
Abstract CT073: A first-in-human study of oral TNO155 (batoprotafib) alone and in combination with EGF816 (nazartinib) in adult patients with advanced solid tumors
Cancer Research·2025· 1 cited
Asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase without BCR::ABL1T315I treated with at least 2 prior TKIs: Phase 1 final results
Leukemia·2025· 9 citedOpen Access
Asciminib in combination with imatinib, nilotinib, or dasatinib in patients with chronic myeloid leukemia in chronic or accelerated phase: phase 1 study final results
Leukemia·2025· 9 citedOpen Access
page 1 of 35Next →

Frequent Co-authors

Nagahiro Saijo(13), Atsushi Ohtsu(8), Yoshiro Saito(8), Toru Mukohara(7), Kimie Sai(7), Noboru Yamamoto(7), Kuniaki Shirao(7), Naomi Kiyota(6), Shogo Ozawa(6), Nahoko Kaniwa(6), Hirofumi Mukai(6), Hiromichi Ebi(5), Mayumi Saeki(5), Makoto Tahara(5), Yoshinori Imamura(4), Yohei Shimono(4), Naoko Chayahara(4), Yasuhide Yamada(4), Koji Matsumoto(4), Kazuo Komamura(4)